Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

REJSEKLINIKKEN ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.8% 0.8%   Bankruptcy risk   2.2% 2.0% 1.4% 2.6% 2.8% 1.6% 9.8% 9.8%   Credit score (0-100)   67 70 78 60 59 73 25 25   Credit rating   BBB A A BBB BBB A BB BB   Credit limit (kDKK)   0.1 0.3 14.8 0.0 0.0 7.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,790 1,303 1,437 1,153 1,704 2,648 0.0 0.0   EBITDA   873 356 534 512 1,159 1,933 0.0 0.0   EBIT   866 349 523 485 1,159 1,933 0.0 0.0   Pre-tax profit (PTP)   856.5 339.8 507.8 546.1 871.3 2,113.5 0.0 0.0   Net earnings   670.3 262.5 392.5 422.8 684.3 1,632.8 0.0 0.0   Pre-tax profit without non-rec. items   857 340 508 546 871 2,114 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   19.0 12.7 27.3 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   1,038 1,192 1,474 1,784 2,354 3,012 2,887 2,887   Interest-bearing liabilities   243 253 446 108 109 114 0.0 0.0   Balance sheet total (assets)   1,515 1,727 2,409 2,167 2,706 3,755 2,887 2,887   Net Debt   -623 -1,214 -1,581 -1,770 -2,381 -632 -2,887 -2,887     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,790 1,303 1,437 1,153 1,704 2,648 0.0 0.0   Gross profit growth   51.9% -27.2% 10.2% -19.7% 47.8% 55.4% -100.0% 0.0%   Employees   3 3 2 2 1 1 0 0   Employee growth %   50.0% 0.0% -33.3% 0.0% -50.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,515 1,727 2,409 2,167 2,706 3,755 2,887 2,887   Balance sheet change%   62.8% 14.1% 39.5% -10.0% 24.8% 38.8% -23.1% 0.0%   Added value   872.8 355.8 534.5 511.8 1,186.6 1,932.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -13 -13 3 -55 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   48.4% 26.8% 36.4% 42.0% 68.0% 73.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   70.9% 21.6% 25.3% 24.7% 47.7% 65.7% 0.0% 0.0%   ROI %   87.1% 25.6% 31.1% 29.6% 53.3% 75.9% 0.0% 0.0%   ROE %   88.7% 23.5% 29.4% 26.0% 33.1% 60.9% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   68.5% 69.0% 61.2% 82.3% 87.0% 80.2% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -71.3% -341.3% -295.8% -345.7% -205.4% -32.7% 0.0% 0.0%   Gearing %   23.4% 21.2% 30.3% 6.1% 4.6% 3.8% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.2% 3.9% 4.3% 6.7% 267.4% 7.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.9 2.8 2.2 5.1 7.1 1.3 0.0 0.0   Current Ratio   3.1 3.1 2.5 5.7 7.7 2.1 0.0 0.0   Cash and cash equivalent   865.9 1,467.4 2,027.0 1,877.5 2,490.3 746.5 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,018.8 1,147.5 -53.1 108.9 556.1 825.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   291 119 267 256 1,187 1,933 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   291 119 267 256 1,159 1,933 0 0   EBIT / employee   289 116 261 242 1,159 1,933 0 0   Net earnings / employee   223 87 196 211 684 1,633 0 0